Possibilities of assessing the drug response of lipid-lowering therapy using genetic markers

Pharmacogenetic studies have revealed a number of genes whose mutations alter the pharmacological effects of statins, and the discovery of the SORT1 gene has opened the way to the study of previously unforeseen goals and therapies in the treatment of coronary heart disease.